C-mo Medical Solutions, an Almada, Portugal-based digital health startup, announced an extension to its seed investment round.
Novalis Biotech joined the seed investment round led by Boehringer Ingelheim Venture Fund and participation from Portugal Ventures and High-Tech Gründerfonds (HTGF).
The round, which now totals €4.8m, will allow the company to further expand the capabilities and applications of their technology.
Led by Diogo Tecelão, co-founder and CEO, C-mo Medical Solutions develops solutions for the diagnosis and management of cough-incident medical conditions.
FinSMEs
30/01/2023